-
-
-
-
-
-
-
BeiGene, Ltd. (ONC) Tops Q4 EPS by 42c, provides guidance
-
-
-
-
-
-
-
Biotech stocks: Q3 earnings preview
-
-
-
-
-
-
-
BeOne Medicines Receives Positive CHMP Opinion for Tablet Formulation of BRUKINSA®
-
-
-
-
-
-
-
BeiGene to Announce First Quarter 2025 Financial Results on May 7
-
-
-
-
-
-
-
BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27
-
-
-
-
-
-
-
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
-
-
-
-
-
-
-
Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights
-
1,231,050 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


